关于我们

我们的故事

Avisi Technologies 于 2017 年通过美国宾夕法尼亚大学 Y-Prize 计划成立。在那时,Avisi 创始人立志运用新的纳米技术来对抗视力丧失和预防失明。在材料科学工程和眼科学的跨学科努力之下,VisiPlate 技术诞生。在校长创新奖、美国国家科学基金会小型企业创新研究 (SBIR) 基金、MedTech Innovator 等的初始支持下,Avisi 大幅加快了成长步伐。

如今,Avisi 的多元化专家团队仍然致力于实现我们的使命——恢复健康,提升活力!我们将携手共创一个美好的世界,让所有人都能享受尖端的医疗解决方案。

领导能力

Rui Jing Jiang

Rui Jing Jiang

Founder, CEO, and Director

LinkedIn

Jeff Emery, PhD

Senior VP of R&D and Operations

LinkedIn

Georgia Griggs, MSE

Principal Engineer, Site Head

LinkedIn

Catherine Mohr, MD, MSME

Director of the Board

LinkedIn

Gary Pruden

Director of the Board

LinkedIn

Paul Norris, JD

Director of the Board

LinkedIn
Brandon Kao, MD

Brandon Kao, MD

Founder and Director

LinkedIn

科学顾问委员会

Eydie Miller-Ellis, MD

Director of the Glaucoma Fellowship Program at Scheie Eye Institute and Professor of Clinical Ophthalmology at University of Pennsylvania

Website

Richard A. Lewis, MD

Former Director of Glaucoma at the University of California, Davis, past President of ASCRS, past President of American Glaucoma Society, and Co- Founder, Sacramento Eye Consultants

Website

Iqbal (Ike) K. Ahmed, MD, FRCSC

Head of Ophthalmology at Trillium Health Partners, Chief Innovation Officer at Prism Eye Institute, Professor of Ophthalmology at University of Utah and John Moran Eye Center

Website

Ehsan Sadri, MD, FACS, FAAO

Founder and CEO of Visionary Eye Institute, Founding Board Member of Visionary Ventures Fund.

Website

Vance Thompson, MD

President of ASCRS, Director of Refractive Surgery at Vance Thompson Vision, Professor of Ophthalmology at Sanford USD School of Medicine

Website

Jonathan S. Myers, MD

Director of Wills Eye Hospital Glaucoma Service and Professor, Sidney Kimmel Medical College at Thomas Jefferson University

Website

Vivian Lee, MD

Co-director of the William C. Frayer Ophthalmic Pathology Laboratory and Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania

Website

Georges Durr, MD, FRCSC

Surgeon at CHUM, Associate Clinical Professor at the University of Montreal

Website
Joseph F. Panarelli, MD Avisi Technologies As an ophthalmologist at NYU Langone, I have the unique opportunity to work with a diverse patient population because I manage glaucoma in adults and children. Through these experiences, I’m able to build long-term relationships with patients, which I find extremely rewarding. I chose to specialize in glaucoma because it allows me to provide ongoing medical care and surgical treatments to patients to improve their quality of life. Through clinical and academic opportunities in the specialty of glaucoma, I can offer meaningful patient care. During my clinical training and my early academic career, most of my research focused on the surgical management of glaucoma. I have published about several new surgical techniques as well as new findings comparing traditional glaucoma procedures to current ones. I have also been part of numerous clinical trials for new surgical devices for eye procedures. Joseph F. Panarelli, MD

Joseph F. Panarelli, MD

Director of Glaucoma Services, NYU Langone Health and Professor of Ophthalmology at NYU Grossman School of Medicine

Website

Barry Cheskin, MS, MBA

President & CEO and Co-Founder, Powervision (acq. Alcon)

LinkedIn

Samuel Nicaise, PhD

Electrical engineering and microscale materials expert

LinkedIn

加入我们的团队:构筑医疗保健的未来

Avisi 的使命是恢复健康和提升活力。我们期望创造一个每个人都能享受尖端医疗保健解决方案的美好世界。

青光眼是世界上导致不可逆失明的主要原因,作为我们团队的一员,您将处于开发下一代青光眼治疗的前沿。

  • 我们在 LinkedIn 上发布全职职位空缺信息,如欲获取此类信息,您可以在 LinkedIn 上关注我们。
  • Avisi 的实习生有机会在 8-10 周内参与 1-2 个项目。
  • 我们非常欢迎对医疗技术创新感兴趣的学生朋友们。实习前建议至少 完成2年的本科课程学习和研究,这有利于您获得优质的实习体验。

 

如需全职工作和实习机会,请随时通过 info@avisitech.com 联系我们。

Avisi team

支持我们的愿景:携手前行,共谋发展

Avisi 得到了风险投资者、知名大学、美国国家科学基金会 (NSF) 和 AdvaMed Accel 等行业团体的支持。得益于强生公司 JLABS 孵化器的成员身份以及 MedTech Innovator Accelerator 和加州大学旧金山分校 (UCSF) Rosenman Innovator 项目的校友身份,我们的旅程受到了更多的关注。

如果您对投资机会感兴趣,请通过 info@avisitech.com 联系我们。

Transparent globe with insufficient data in a wireframe design on a blue background with reflection below.

支持机构

Accanto Partners Logo
Life Sciences Greenhouse Investments Logo
MedVenture Partners
Mountain State Capital Logo
Skip to content